Blood from survivors could spur treatments

Project will inject people with genetic material to trigger creation of specific antibiotics

After successfully treating four Ebola patients last year, Emory University in Atlanta is now leading a government-funded project that will use blood from survivors of the deadly virus to test a novel way of treating infectious disease.

Traditional vaccines boost the immune system's response to infections. The new project will inject people with genetic material, such as DNA or RNA, in hopes of spurring a person's own cells to make specific antibodies capable of fighting Ebola or other pathogens.